Fundraising Fox
/People
Sign in

Karl Handelsman

Investor

Founder and Managing Partner at Codon Capital · General Partner at Codon Innovation · SPARK Selection Committee at Stanford University · Board director at Bonum Therapeutics

San Francisco, California

Writes $100K – $5M checks · typically $1.5M

Find your path to Karl

1,767 people in our graph share verified history with Karl — schools, employers, funds. One of them is your warm intro.

Logan HilleunlockedKarl: together at UCSF (2016)
×11Karl: together at UCSF

About

Karl Handelsman is founder and managing partner of Codon Capital, where he invests in early-stage pre-clinical therapeutics and synthetic biology companies. His investment portfolio includes multiple companies that achieved acquisitions or IPOs within 18 months of founding. His experience spans biotech company formation and early-stage investing.

Board director at Bonum Therapeutics

Intro paths

→

In turn, Karl can intro founders to Bonum Therapeutics's investors below.

Bonum Therapeutics's investors · 6

3x5 PartnersPortlandCodon CapitalSan Francisco · since 2022Digitalis VenturesNew York · $100K – $10M checks · since 2022RiverVest Venture PartnersSt. Louis · $500K – $3M checks · since 2026Roche Venture FundBasel · $648K – $3.2M checks · since 2022Vivo CapitalPalo Alto · $10M – $50M checks

Co-founders at Bonum Therapeutics

JMJohn Mulligan
John MulliganExecutive Officer, Director, Promoter

Experience

  1. Codon CapitalFounder & Investorcurrent2013 — presentSan Francisco Bay Area- home base
  2. UCSFCatalyst Advisory Panelcurrent2013 — presentSan Francisco Bay Area
  3. UCSFLean Launchpad for Therapeutics/Tools Instructor2013 — 2016UCSF
  4. Stanford UniversitySPARK Selection Committeecurrent2013 — presentPalo Alto, CA
  5. Life Science AngelsMember2014 — 2025San Francisco Bay Area
  6. GenentechSenior Advisor, Roche Venture Fund2016 — 2021South San Francisco CA
  7. California Inst. for Regenerative MedicineMentor2013 — 2016San Francisco Bay Area
  8. CMEA CapitalGeneral Partner Emeritus2013 — 2014San Francisco Bay Area
  9. CMEA CapitalManaging Director/General Partner1999 — 2013San Francisco Bay Area
  10. Millennium PharmaceuticalsDirector, Business Development1996 — 1997Cambridge, MA
  11. TularikManager, Business Development1992 — 1996South San Francisco, CA

Skills & more

Strategy22Strategic Planning11Relationship Building5Biotechnology99Entrepreneurship99Venture Capital99Start-ups77Commercialization70Lifesciences61Corporate Development43Life Sciences62Pharmaceutical Industry37
+12 moreMergers & AcquisitionsTechnology TransferBusiness DevelopmentPrivate EquityStrategic PartnershipsDue DiligenceDrug DiscoveryDrug DevelopmentAngel InvestingStart-up VenturesCapital RaisingVenture Financing

From Karl's professional profile.

Investments

Per curated public sources.

Frequently asked questions

Who is Karl Handelsman?
Karl Handelsman is founder and managing partner of Codon Capital, where he invests in early-stage pre-clinical therapeutics and synthetic biology companies. His investment portfolio includes multiple companies that achieved acquisitions or IPOs within 18 months of founding. His experience spans biotech company formation and early-stage investing.
Where does Karl Handelsman work?
Karl Handelsman is Founder and Managing Partner at Codon Capital and Board director at Bonum Therapeutics.
What check size does Karl Handelsman write?
Karl Handelsman typically writes checks of $100K – $5M.
What companies has Karl Handelsman invested in?
Investments tracked here include Bonum Therapeutics, Clear Labs, Good Therapeutics.
Where did Karl Handelsman go to school?
Karl Handelsman studied at MIT Sloan School of Management (Master of Business Administration (MBA), Business Administration and Management); Harvard Medical School (Master of Science (M.S.), Genetics); Boston University (Bachelor of Arts (B.A.), Biology).

Same school

Shared employers